Stocks · Health care · Pharmaceutical Preparations

Theravance Biopharma, Inc.

TBPH Clue Score61

United States Fiscal year ends December CIK 0001583107 Results filed 10 Aug 2026

Add to watchlist

What the insiders did Net buying

Bought (120 mo)

$22.27M

out of their own pocket, the only kind of buying there is

Sold (120 mo)

$17.54M

$2.08M on a plan · $1.66M straight out of an exercise

Sold at will

$13.79M

44 of 75 sales

Net

+$4.73M

+$8.48M against sales at will